These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model. Yukawa E, Suematu F, Yukawa M, Minemoto M, Ohdo S, Higuchi S, Goto Y, Aoyama T. Clin Pharmacokinet; 2001; 40(10):773-81. PubMed ID: 11707062 [Abstract] [Full Text] [Related]
8. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update. Yukawa E, Honda T, Ohdo S, Higuchi S, Aoyama T. J Clin Pharmacol; 1997 Feb; 37(2):92-100. PubMed ID: 9055134 [Abstract] [Full Text] [Related]
9. The effects of captopril on serum digoxin levels in patients with severe congestive heart failure. Kirimli O, Kalkan S, Guneri S, Tuncok Y, Akdeniz B, Ozdamar M, Guven H. Int J Clin Pharmacol Ther; 2001 Jul; 39(7):311-4. PubMed ID: 11471775 [Abstract] [Full Text] [Related]
15. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense? el-Desoky ES, Madabushi R, Amry Sel-D, Bhattaram VA, Derendorf H. Am J Ther; 2005 Jul; 12(4):320-7. PubMed ID: 16041195 [Abstract] [Full Text] [Related]
17. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization. EL Desoky ES, Nagaraja NV, Derendorf H. Am J Ther; 2002 Jul; 9(6):492-8. PubMed ID: 12424506 [Abstract] [Full Text] [Related]